Abstract
Background
Navilas® laser is a novel technology combining photocoagulation with imaging, including fluorescein angiographic (FA) images which are annotated and aligned to a live fundus view. We determine the time necessary for planning and treatment of macular edema utilizing the Navilas®.
Methods
The screen recordings during treatments were retrospectively analyzed for treatment type, number of laser shots, the duration of planning (measured from the time the planning image was selected to time of marking the last planned treatment spot), and total time of laser application.
Results
A total of 93 treatments (30 grid, 30 focal and 33 combined treatments) by four physicians from three sites were included. An average of 125 spots were applied to each eye. The total time spent for each focal treatment - including the planning was 7 min 47 s (±3 min and 32 s).
Conclusions
Navilas® is a novel device providing a time efficient platform for evaluating FA images and performing threshold macular laser photocoagulation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Heier JS, Campochiaro PA, Yau L, Li Z, Saroj N, Rubio RG, Lai P (2012) Ranibizumab for macular edema Due to retinal vein occlusions long-term follow-up in the HORIZON trial. Ophthalmology 119(4):802–809
SCORE Study Research Group (2009) A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 5. Arch Ophthalmol 127:1101–1114
SCORE Study Research Group (2009) A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 6. Arch Ophthalmol 127:1115–1128
Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO, Sutter F, Simader C, Burian G, Gerstner O, Weichselberger A (2011) The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 118(4):615–625
Soheilian M, Garfami KH, Ramezani A, Yaseri M, Peyman GA (2012) Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema. Retina 32(2):314–321
Elman MJ, Bressler NM, Qin H, Beck RW, Ferris FL, Friedmans SM, Glassman AR, Scott IU, Stockdale CR, Sun JK, Diabetic Retinopathy Clinical Research Network (2011) Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 118(4):609–614
Nguyen QD, Shah SM, Khwaja AA, Channa R, Hatef E, Do DV, Boyer D, Heier JS, Abraham P, Thach AB, Lit ES, Foster BS, Hruger E, Dugel P, Chang T, Das A, Ciulla TA, Pollack JS, Lim JI, Eliott D, Campochiaro PA (2010) Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology 117:2146–2151
Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, Edwards AR, Ferris FL, Friedman SM, Glassman AR, Miller KM, Scott IU, Stockdale CR, Sun JK (2010) Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 117:1064–1077
The Branch Vein Occlusion Study Group (1984) Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 98(3):271–282
Early Treatment Diabetic Retinopathy Study Research Group (1985) Photocoagulation for diabetic macular edema Study report number 1. Arch Ophthalmol 103:1796–1806
Shah A, Bressler NM, Jampol LM (2011) Does laser still have a role in the management of retinal vascular and neovascular disease? Am J Ophthalmology 152(3):332–339
Blumenkranz MS, Yellachich D, Andersen DE, Wiltberger MW, Mordaunt D, Marcellino GR, Palanker D (2006) Semiautomated patterned scanning laser for retinal photocoagulation. Retina 26(3):370–376
Kozak I, Oster SF, Cortes MA, Dowell D, Hartmann K, Kim JS, Freeman WR (2011) Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagulator NAVILAS. Ophthalmology 118(6):1119–1124
Kernt M, Cheuteu R, Vounotrypidis E, Haritoglou C, Kampik A, Ulbig MW, Neubauer AS (2011) Focal and panretinal photocoagulation with a navigated laser (NAVILAS®). Acta Ophthalmologica 89(9):662–664
Kozak I, Kim JS, Oster SF, Chhablani J, Freeman WR (2012) Focal navigated laser photocoagulation in retinovascular disease: clinical results in initial case series. Retina 32(5):930–935
Kernt M, Cheuteu R, Liegl RG, Seidensticker F, Cserhati S, Hirneiss C, Haritoglou C, Kampik A, Ulbig M, Neubauer AS (2012) Navigated focal retinal laser therapy using the NAVILAS® system for diabetic macula edema (Article in German). Ophthalmologe (Epub ahead of print)
Author information
Authors and Affiliations
Corresponding author
Additional information
Presented as a poster at the Association for Research in Vision and Ophthalmology in Ft. Lauderdale, FL, USA in 2011. The authors have not received any support for this research, and do not have any financial interest in publishing this study.
Rights and permissions
About this article
Cite this article
Ober, M.D., Kernt, M., Cortes, M.A. et al. Time required for navigated macular laser photocoagulation treatment with the Navilas®. Graefes Arch Clin Exp Ophthalmol 251, 1049–1053 (2013). https://doi.org/10.1007/s00417-012-2119-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-012-2119-0